| |
| |
|
| Insider
Information: |
Aryeh Jason |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
401,047 |
|
|
Indirect Shares
|
890,847 |
|
|
| Direct
Value |
$7,148,144 |
|
|
|
Indirect Value
|
$4,945,268 |
|
|
| Total
Shares |
1,291,894 |
|
|
| Total
Value |
$12,093,412 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ligand Pharmaceuticals Inc |
LGND |
Director |
2024-04-30 |
76,828 |
2024-04-30 |
56,619 |
Premium* |
|
|
Vaxart Inc |
VXRT |
Director |
2010-12-27 |
0 |
2011-03-15 |
131,783 |
Premium* |
|
|
Myrexis Inc |
MYRX |
Director |
|
0 |
2012-06-15 |
552,145 |
Premium* |
|
|
Novelion Therapeutics Inc |
NVLN |
Director |
2017-05-15 |
242,433 |
2017-05-15 |
150,300 |
Premium* |
|
|
Aralez Pharmaceuticals Inc. |
ARLZ |
Director |
2017-05-23 |
15,000 |
2017-05-23 |
0 |
Premium* |
|
|
Merrimack Pharmaceuticals Inc |
MACK |
See Explanation of Res... |
2019-07-16 |
3,802 |
2019-07-11 |
0 |
Premium* |
|
|
Orchestra BioMed Holdings Inc. |
OBIO |
Director |
2023-04-12 |
62,984 |
2023-01-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
175 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-10-20 |
4 |
S |
$5.01 |
$42,851 |
I/I |
(8,553) |
223,883 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Director |
– • – |
2015-12-29 |
4 |
B |
$2.49 |
$45,996 |
I/I |
18,400 |
461,478 |
2.1 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-03-19 |
4 |
S |
$5.99 |
$46,722 |
I/I |
(7,800) |
345,420 |
0 |
- |
|
| MYRX |
Myrexis Inc |
Director |
– • – |
2012-01-31 |
4 |
OE |
$5.00 |
$47,500 |
I/I |
9,500 |
495,536 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-02-23 |
4 |
B |
$9.94 |
$49,700 |
I/I |
5,000 |
267,111 |
2.1 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2016-03-08 |
4 |
S |
$102.49 |
$51,245 |
I/I |
(500) |
235,707 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2019-05-31 |
4 |
AB |
$108.51 |
$54,255 |
D/D |
500 |
60,618 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-10-18 |
4 |
S |
$5.00 |
$60,100 |
I/I |
(12,020) |
232,436 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-11-10 |
4 |
S |
$5.39 |
$60,402 |
I/I |
(11,200) |
206,283 |
0 |
- |
|
| MYRX |
Myrexis Inc |
Director |
– • – |
2011-11-23 |
4 |
B |
$2.50 |
$63,620 |
I/I |
25,499 |
161,465 |
2.1 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2019-09-03 |
4 |
AB |
$87.01 |
$65,258 |
D/D |
750 |
67,203 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2019-08-05 |
4 |
AB |
$90.01 |
$67,146 |
D/D |
746 |
66,453 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-03-17 |
4 |
S |
$5.94 |
$67,881 |
I/I |
(11,419) |
359,201 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2019-07-31 |
4 |
AB |
$93.00 |
$70,122 |
D/D |
754 |
65,707 |
0 |
- |
|
| MYRX |
Myrexis Inc |
Director |
– • – |
2011-12-02 |
4 |
B |
$2.69 |
$74,299 |
I/I |
27,600 |
430,244 |
2.1 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-01-13 |
4 |
AS |
$5.49 |
$75,774 |
I/I |
(13,800) |
587,420 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2017-05-19 |
4 |
S |
$1.56 |
$79,558 |
I/I |
(51,041) |
337,644 |
0 |
- |
|
| MYRX |
Myrexis Inc |
Director |
– • – |
2011-12-05 |
4 |
B |
$2.75 |
$84,801 |
I/I |
30,792 |
461,036 |
2.1 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-12-27 |
4 |
S |
$5.74 |
$86,634 |
D/D |
(15,093) |
0 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2015-05-20 |
4 |
S |
$87.65 |
$87,650 |
I/I |
(1,000) |
246,476 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-03-10 |
4 |
AS |
$5.74 |
$92,414 |
I/I |
(16,100) |
568,120 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-03-12 |
4 |
S |
$5.93 |
$98,374 |
I/I |
(16,600) |
370,820 |
0 |
- |
|
| MYRX |
Myrexis Inc |
Director |
– • – |
2011-11-25 |
4 |
B |
$2.51 |
$105,268 |
I/I |
41,956 |
203,421 |
2.1 |
- |
|
| MYRX |
Myrexis Inc |
Director |
– • – |
2011-12-01 |
4 |
B |
$2.65 |
$112,895 |
I/I |
42,618 |
402,644 |
2.1 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2024-03-05 |
4 |
OE |
$39.35 |
$113,840 |
D/D |
2,893 |
74,422 |
0 |
- |
|
175 Records found
|
|
Page 5 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
